Listeria meningitis after infliximab treatment of ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 50, Issue 3, 2010, Pages 337-339

  Chuang, Maria H ^a   Singh, Jasjit ^a   Ashouri, Negar ^a   Katz, Mitchell H ^a   Arrieta, Antonio C ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GENTAMICIN; INFLIXIMAB; MERCAPTOPURINE; MEROPENEM; MESALAZINE; METHYLPREDNISOLONE; PLASMA SUBSTITUTE; PREDNISONE; RIFAMPICIN;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADOLESCENT; ARTICLE; BLOOD CULTURE; BRAIN TOMOGRAPHY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILL; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GRAM POSITIVE BACTERIUM; HEADACHE; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LETHARGY; LEUKOCYTE COUNT; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MENTAL HEALTH; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; TREATMENT DURATION; ULCERATIVE COLITIS; URTICARIA; VOMITING;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; HUMANS; MALE; MENINGITIS, LISTERIA; OPPORTUNISTIC INFECTIONS;

LISTERIA;

EID: 77649298069     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181a70f3a     Document Type: Article

References (32)

1. Kamath BM, Mamula P, Baldassano RN, et al. Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr 2002;34:410-413
2. Slutsker L, Schuchat A. Listeriosis in humans. In: Ryser ET, Marth EH (eds). Listeria, Listeriosis, and Food Safety. 2nd ed.New York: Marcel Dekker; 1999. pp. 75-95.
3. Lorer B. Listeria monocytogenes. In: Mandell GL, Bennett JE, Dolin R (eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease, Vol.2. 5th ed.Philadelphia: Churchill Livingstone; 2000. pp. 2208-2215
4. Schuchat A, Deaver KA, Wenger JD, et al. Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. JAMA 1992; 267:2041-2045
5. Skogberg K, Syrjanen J, Jahkola M, et al. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 1992;14:815-821
6. Nieman RE, Lorber B. Listeriosis in adults; a changing pattern. Report of eight cases and reviews of the literature, 1968-1978. Rev Infect Dis 1990;2:207-227
7. Unanue ER. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol Rev 1997;158: 11-25.
8. Edelson BT, Unanue ER. Immunity to Listeria infection. Curr Opin Immunol 2000;12:425-431
9. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 1988;56:2563-2569
10. Rothe J, LesslauerW, Lotscher H, et al. Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993;364: 798-802.
11. Van Furth R, van Zwet TL, Buisman AM, et al. Anti-tumor necrosis factor antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudates and enhance the growth of Listeria monocytogenes in various organs. J Infect Dis 1994;170:234-237
12. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-1725 (Pubitemid 26193625)
13. O'Dell JR. Anticytokine therapy: a new era in the treatment of rheumatoid arthritis? N Engl J Med 1999;340:310-312
14. Choy EHS, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-916
15. Schluter D, Deckert M. The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect 2000;2:1285-1292
16. Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993;34:1705-1709
17. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997;159:6276-6282
18. Van Deventer SJH. Tumor necrosis factor and Crohn's disease. Gut 1997;40:443-448
19. Lugering A, Schmidt M, Lugering N, et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001;121:1145-1157
20. Ten Hove T, van Montfrans C, Peppelenbosch MP, et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002;50:206-211
21. Hanauer SB, Feagan BG, Lichtenstein GR, et al., ACCENT I Study GroupMaintenance infliximab for Crohn's disease; the ACCENT I randomized trial. Lancet 2002;359:1541-1549
22. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 353:2462-2476 (Pubitemid 41770166)
23. Wilhelm SM, McKenney KA, Rivait KN, et al. A review of infliximab use in ulcerative colitis. Clin Ther 2008;30:223-230
24. Morelli J, Wilson FA. Does administration of infliximab increase susceptibility to listeriosis? Am J Gastroenterol 2000;95:841-842
25. Slifman NR, Gershon SK, Lee JH, et al. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 2003;48:319-324
26. Schaible TF. Important drug warning (Centocor). FDA Web site. October 4, 2001. http://www.fda.gov/medwatch/safety/2001/safety01. htm#remica. Accessed October 26, 2008.
27. Yildiz O, Aygen B, Esel D, et al. Sepsis and meningitis due to Listeria monocytogenes. Yonsei Med J 2007;48:433-439
28. Sobrevilla LA, Tedeschi LG, Cronin JF, et al. Listeria monocytogenes meningitis as a complication of steroid therapy. BMQ 1962;13:62-66
29. Gantz NM, Myerowitz RL, Medeiros AA, et al. Listeriosis in immunosuppressed patients: a cluster of eight cases. Am J Med 1975;58:637-643
30. Mora J, White M, Dunkel IJ. Listeriosis in pediatric oncology patients. Cancer 1998;83:817-820
31. Heger W, Dierich MP, Allerberger F. In vitro susceptibility of Listeria monocytogenes: comparison of the E test with the agar dilution test. Chemotherapy 1997;43:303-310
32. Nairn K, Shepherd GL, Edawards JR. Efficacy of meropenem in experimental meningitis. J Antimicrob Chemother 1995;36 (Suppl. A):73-84.